this slide share will provide the information about orphan diseases and its management . this will give the introduction of orphan disease , what are drugs used for these diseases and how the diseases can be managed.
1 of 14
Download to read offline
More Related Content
Orphan diseases and its management
1. ORPHAN DISEASES AND ITS
MANAGEMENT
K.VISHNUPRIYA,
M.Pharm(pharmacology),
Ratnam institute of pharmacy,
Nellore.
2. INTRODUCTION
WHO Defines Orphan/ rare disease are All pathogenic conditions are
affected by 0.65 1% out of every 1000 inhabitants.
The European organization defines Orphan is one with prevalence of
5:10,000 Europeans.
USA defines it is an aliment affecting fewer than 2,00,000 Americans.
Australia defines it is an aliment affecting fewer than 2,000.
India defines it is an aliment affecting fewer than 50,000 Indian patients.
Orphan drugs :
The drugs which used to treat Orphan diseases are called as Orphan
drugs.
Eg: Haem arginate acute
Intermittent porphyria
Ibuprofen dutus arteriosus
3. INTRODUCTION
Orphan drug law :
In 1984 United states promulgated the 1st law which is specially
designed to encourage R&D investments in areas usually neglected by
pharmaceutical companies.
Subsequently other countries like Japan(1993), Australia(1998) and
European union(2000) have adopted similar laws.
India follows the European laws
The Orphan drug law depends on 2 criteria
1. Epidemiological criterion:
The product is aimed to cure or treat the disease with low prevalence
2. Economic criterion: Irrespective of disease prevalence, there is no
reasonable expectation R&D production cost will be recovered by sale
revenues in countries where the Orphan status is granted.
4. INTRODUCTION
Incentives of pharmaceutical companies:
1. Push mechanisms: these are incentives that operates upstream during
R&D process and involve costs to the public sector, such as tax credits and
research grants.
2. Pull mechanisms: these are incentives that operates downstream reward
the research output and offers public incentives for development of product.
5. Various orphan diseases
Name of Pathophysiology Age of % of Symptoms Management
the disease occurrence occurrence
1.Handigodu It is an inherited 10 yrs to 0.01% sever joint & hip no cure but
syndrome degenerative adult pains, dwarfism, pain manage-
osteoarthropathy deformation of - ment is
limbs available
2. Acromegaly it is characterized Adults 0.02% skeletal & soft tissue Octreotide,
by exaggerated growth deformities, Lanreotide,
somatic growth due teeth separation, wt Cabergoline,
to increased growth gain, fatigue & heat Pegvisomant
hormone secretion intolerance
in an adult after
the epiphysis
6. Various orphan diseases
Name of the Pathophysiology Age of % of Symptoms Management
Disease occurrence occurrence
3. Muscular it is rare inborn copper Weakness, muscle Glucocorticiods,
dystrophy storage disorder which All 0.02% atrophy& elevated physiotherapy
is characterized by levels of serum & gene therapy
progressive skeletal enzyme creatinine
muscle weakness. kinase
4. Grave
disease it is an autoimmune Adult 0.03% Hyper thyroidism, Anti thyroid
disease which affect Anti thyroid unusual drugs
affect thyroid gland intolerance to heat,
fatigue, wt loss &
protrusion of eye
balls
7. Various orphan diseases
Name of the Pathophysiology Age of % of Symptoms Management
disease occurrence occurrence
5.
osteopetrosis it is characterized All 0.04% in infants- life No cure is availa-
by increased bone threatening bone -ble but hemato-
mass, failure of marrow failure -poitic stem cell
osteoclats function in adults- bone transplantation,
as a result of fractures vit-D &
mutation in multi- erythropoietin for
-ple genes human symptomatic
relief
6. Porphyria it is most common All 0.04% Blisters, bullae, Antibiotics, 4-
cutenia tarda human porphyria increased fragility, aminoquinolines,
due to acquired scaring, hyper-hypo Iron chelating
deficient activity pigmentation of agents &
of hepatic UROD. Sun exposed areas erythropoietin
it catalyzes copro
porphyrinogen &
causes tissue
damage
8. Various orphan diseases
Name of Pathophysiology Age of % of Symptoms Management
the disease occurrence occurrence
7.
Myasthenia it is an autoimmune All 0.06% Diplopia, eye Cholinesterase
gravis neuromuscular lid moment, inhibitors,
junction disorder swallowing, corticosteroids
which is caused due fatigue & facial with immuno
to problems in trans expression modulators
-mission of nerve
signals to muscles
8.
Parkinsons it is an progressive Elderly 0.5% tremors, brady Levodopa,
disease neuro-degenerative kinesia, gait & Carbidopa,
moment disorder muscular rigidity Dopamine
that impairs speech, Pramipexole
moment & others
9. Various orphan diseases
Name of Pathophyisiology Age of % of Symptoms Management
the disease occurrence occurrence
9. Rabies it is an infectious All 0.06% pains, parasthesia, cell culture
viral disease which fever, encephalitis, rabies
affects human, hydrophobia, vaccine
domestic & wild Aerophobia, photo
animals phobia & paralysis
10.
Alkaptonuria it is an autosomal Congenital 2% joint pains, black Nitisinone
recessive genetic sports appears in
disease. In which the whites of eyes,
patients inherit 2 pigmentation in
defective copies of ligament & tendons
a gene one from cardio vascular
each parent problems
10. Various orphan diseases
Name of the Pathophysiology Age of % of Symptoms Management
disease occurrence occurrence
11. Gauchers it causes due to Congenital 2% Hepatospleeno- enzyme
disease deficiency of - megaly replacement
glucocerebrosidase therapy &
enzyme which is surgical removal
responsible for of spleen&/liver
break down of part to improve
fatty substances affected person
called Gluco - comfort
- cerebrosides
12. Kyasanur it is an infectious Adult 5% chills, frontal no treatment
forest disease bleeding disease head ache, high is available
in monkeys & fever, vomiting,
human caused by diarrhea, cough,
pathogenic virus sever pain in
called KFD virus neck & low back
11. Various orphan diseases
Name of the Pathophysiology Age of % of Symptoms Management
disease occurrence occurrence
13. Alpha-1- affected people Congenital 5% chronic obstructive Lung
antitrypsin have lack of alpha- pulmonary disease transplant
deficiency 1 antitrypsin protein less commonly
in their blood due cause liver damage
mutation of SERPINA-1 rarely skin disease
gene. It causes
uncontrolled neu-
-trophil elastage
activity.
14. Madras it is an molecular Adult NA patient look slender no treatment
motor neuron disease, in which facial & bulbar, is available,
disease the pathogenesis hearing loss due to IV Ig is
is unknown nerve defect & available
muscle bilateral
optic atrophy
12. Various orphan diseases
Name of the Pathophysiology Age of % of Symptoms Management
disease occurrence occurrence
15. Ebsteins there is an Congenital 5% Dyspnea, atypical ACE inhibitors
anomaly embryological chest pain, fatigue, Ca2+ channel
malformation of anorexia, decreased blockers,
of tricuspid valve energy from cardiac beta-blockers
leaflets. So, that failure causes venous Diuretics,
there is incomplete congestion in stomach Digoxin
alignment of leaf
lets at AV junction
16. Ehlers it is an inherited Congenital 8% hyper extensibility no drug is
danlos connective tissue of joints & skin, available but
syndrome disorder which vascular changes, life style
results impaired dental abnormalities modifications
formation & & pulmonary & surgery
integrity of alterations
collagen
13. Various orphan diseases
Name of the Pathophysiology Age of % of Symptoms Management
disease occurrence occurrence
17.Wilsons it is an rare inborn Congenital 6% yellowing of skin & copper chelators,
disease copper storage eyes, loss of D-penicillamine
disorder which is appetite, fatigue,
characterized by the trembling, mood
presence of excess swings, difficulty
copper in liver, brain, in walking & speech
kidney & cornea problems
18.Tetralogy TOF arises from Congenital 8% hyperpnea, Nacortic
of fallot single genetic cyanosis, analgesics, PGs,
defect involving the syncope diuretics & beta
TBx gene, which blockers
encodes transcri-
-ption factor
14. Various orphan diseases
Name of Pathophysiology Age of % of Symptoms Management
the disease occurrence occurrence
19. Lupus it is an inflammatory All NA it can affect Anti-malarial
autoimmune disease any organ like drugs, NSAIDs
in which bodys heart, kidneys, like Ibuprofen,
immune system attack blood vessels, steroids,
its own healthy tissues joints/skin, immuno -
& causes inflammation skin rashes, supressives
joint pains
20. Pulmonic it narrow the pulmonic Congenital NA difficult to
valvular valve & the group of 3 breath, chest valvuloplasty
stenosis leaflets separates right pain, fatigue,
ventricle from the right ventricular
pulmonary trunk hypertrophy &
hypoxemia